Clinical Trials Directory

Trials / Completed

CompletedNCT02062593

Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina

Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
230 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In this study the investigators will use careful scientific blinding of patient and their subsequent healthcare staff so that the investigators can determine exactly how much difference coronary angioplasty makes to symptoms and blood supply to the heart. After the 6 weeks blinded phase, all patients will be unblinded and the patients who had undergone sham procedure will be offered the active therapy.

Detailed description

The investigators will perform a multi-centre prospective randomised double-blinded comparison of the treatment of stable angina with percutaneous coronary intervention (PCI) and optimal medical therapy (OMT) versus a sham procedure and OMT. Two hundred patients with stable angina and one or more angiographically significant coronary stenosis of 70% or more in a single vessel that is suitable for angioplasty will be recruited. Baseline investigation of functional capacity and myocardial ischaemic burden will be performed. This will be followed by a coronary angiogram and invasive physiological investigation followed by randomisation to PCI or a sham procedure. Follow-up investigation of functional capacity and myocardial ischaemic burden at 6 weeks will then be performed.

Conditions

Interventions

TypeNameDescription
PROCEDURECoronary angioplastyPercutaneous coronary intervention with drug-eluting stents and modern techniques

Timeline

Start date
2013-12-01
Primary completion
2017-08-01
Completion
2017-09-01
First posted
2014-02-13
Last updated
2024-01-22
Results posted
2021-04-22

Locations

5 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02062593. Inclusion in this directory is not an endorsement.